Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Viiv Healthcare Company patents


Recent patent applications related to Viiv Healthcare Company. Viiv Healthcare Company is listed as an Agent/Assignee. Note: Viiv Healthcare Company may have other listings under different names/spellings. We're not affiliated with Viiv Healthcare Company, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Viiv Healthcare Company-related inventors


Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

5-(n-benzyl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula (i), including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids. In the compounds of formula (i), r1 is selected from hydrogen, alkyl, or cycloalkyl; r2 is selected from tetrahydroisoquinolinyl and is substituted with 1 r6 substituent and also with 0-3 halo or alkyl substituents; r3 is selected from azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy; r4 is selected from alkyl or haloalkyl; r5 is alkyl; r6 is selected from ar1, (ar1)alkyl, (chromanyl)alkyl, cyanocycloalkyl or (dihydrobenzodioxinyl)alkyl; and ar1 is phenyl substituted with 0-5 substituents selected from cyano, halo, alkyl, cycloalkyl, haloalkyl, hydroxy, alkoxy, haloalkoxy, (hydroxy)alkoxy, (alkoxy)alkoxy, phenoxy, benzyloxy, carboxy, phenyl, and cyanocycloalkyl.. ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv.. . ... Viiv Healthcare Company

Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication

The disclosure generally relates to compounds of formula i, including compositions and methods for treating human immunodeficiency virus (hiv) infection. The disclosure provides novel inhibitors of hiv, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of hiv infection.. ... Viiv Healthcare Company

5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Process for preparing carbamoylpyridone derivatives and intermediates

The present invention relates to the preparation of carbamoylpyridone derivatives such as the compound of formula (viiia):. . The present invention relates to the preparation of carbamoylpyridone derivatives such as the compound of formula (viiia):. . ... Viiv Healthcare Company

Benzoazepine derivatives

Compounds of formula i are disclosed and methods of treating viral infections with compositions comprising such compounds.. . ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Disclosed are compounds of formula i, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting hiv integrase and treating those infected with hiv or aids.. . ... Viiv Healthcare Company

Antiviral therapy

The present invention relates to combinations of compounds comprising hiv integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of hiv replication, the prevention and/or treatment of infection by hiv, and in the treatment of aids and/or arc. ... Viiv Healthcare Company

04/05/18 / #20180094019

Crystalline forms of modified triterpenoid hydrochloride salts with hiv maturation inhibitor activity

The present invention relates to crystalline forms of modified triterpenoid hydrochloride salts with hiv maturation inhibitor activity. More specifically, the present invention relates to the h-4, t1f-1, and t1f-2 crystalline forms. ... Viiv Healthcare Company

03/29/18 / #20180086697

Inhibitors of human immunodeficiency virus replication

Compounds of formula i, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (hiv) infection are set forth:. . ... Viiv Healthcare Company

12/21/17 / #20170362262

A process for preparing halogenated azaindole compounds using pybrop

. . . . . . A process for preparing halogenated azaindole compounds makes use of a brominating agent pybrop, together with a dehydrating agent bsa to enhance the selectivity and improve the yield of the final product which is a piperazine prodrug useful as an antiviral.. . ... Viiv Healthcare Company

10/26/17 / #20170304239

Inhibitors of human immunodeficiency virus replication

. . . . . . Compounds of formula i, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (hiv) infection are set forth:. . ... Viiv Healthcare Company

10/05/17 / #20170281636

Antiviral therapy

The present invention relates to combinations of compounds comprising hiv integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of hiv replication, the prevention and/or treatment of infection by hiv, and in the treatment of aids and/or arc. ... Viiv Healthcare Company

08/03/17 / #20170217890

Phenyl and tertbutylacetic acid substituted pyridinones having anti-hiv effects

. . . . . . . . Compounds of formula i are disclosed and methods of treating viral infections with compositions comprising such compounds.. . ... Viiv Healthcare Company

08/03/17 / #20170216284

Antiviral therapy

The present invention relates to combinations of compounds comprising hiv integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of hiv replication, the prevention and/or treatment of infection by hiv, and in the treatment of aids and/or arc. ... Viiv Healthcare Company

07/20/17 / #20170204117

Process for preparing (4r,12as)-n-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,- 12a-hexahydro-2h-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide

. . . . The present invention relates to the preparation of carbamoylpyridone derivatives and intermediates.. . ... Viiv Healthcare Company

07/20/17 / #20170204058

Isoindolinone derivatives useful as antiviral agents

Compounds of formula i are disclosed and methods of treating viral infections with compositions comprising such compounds.. . ... Viiv Healthcare Company

05/04/17 / #20170119777

Antiviral therapy

The present invention relates to combinations of compounds comprising hiv integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of hiv replication, the prevention and/or treatment of infection by hiv, and in the treatment of aids and/or arc. ... Viiv Healthcare Company

03/23/17 / #20170079982

Antiviral therapy

The present invention relates to combinations of compounds comprising hiv integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of hiv replication, the prevention and/or treatment of infection by hiv, and in the treatment of aids and/or arc. ... Viiv Healthcare Company

03/02/17 / #20170057977

Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

. . The disclosure generally relates to compounds of formula i, including compositions and methods for treating human immunodeficiency virus (hiv) infection. The disclosure provides novel inhibitors of hiv integrase, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of hiv infection.. ... Viiv Healthcare Company

02/02/17 / #20170027933

Pharmaceutical compositions

. . The present invention relates to pharmaceutical compositions of (3s,11ar)—n-[(2,4-difluorophenyhmethyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, useful in the treatment or prevention of human immunodeficiency virus (hiv) infections.. . ... Viiv Healthcare Company

01/19/17 / #20170015683

Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

The disclosure generally relates to compounds of formula i, including compositions and methods for treating human immunodeficiency virus (hiv) infection. The disclosure provides novel inhibitors of hiv, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of hiv infection.. ... Viiv Healthcare Company

01/12/17 / #20170008912

Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication

The disclosure generally relates to compounds of formula i, including compositions and methods for treating human immunodeficiency virus (hiv) infection. The disclosure provides novel inhibitors of hiv, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of hiv infection.. ... Viiv Healthcare Company

01/12/17 / #20170008887

Inhibitors of human immunodeficiency virus replication

The disclosure generally relates to compounds of formula i, including compositions and methods for treating human immunodeficiency virus (hiv) infection. The disclosure provides novel inhibitors of hiv, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of hiv infection.. ... Viiv Healthcare Company








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Viiv Healthcare Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Viiv Healthcare Company with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###